9,628 Shares in Danaher Corporation $DHR Bought by Canandaigua National Bank & Trust Co.

Canandaigua National Bank & Trust Co. bought a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 9,628 shares of the conglomerate’s stock, valued at approximately $1,834,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. Elevated Capital Advisors LLC acquired a new position in shares of Danaher during the fourth quarter worth about $26,000. Hilton Head Capital Partners LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd lifted its stake in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares in the last quarter. JPL Wealth Management LLC bought a new stake in Danaher in the 3rd quarter valued at approximately $25,000. Finally, Main Street Group LTD acquired a new position in Danaher during the 1st quarter worth approximately $25,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 2.4%

DHR stock opened at $199.52 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market capitalization of $140.26 billion, a price-to-earnings ratio of 35.44, a PEG ratio of 2.43 and a beta of 0.78. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business’s fifty day moving average price is $189.84 and its two-hundred day moving average price is $194.50.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 EPS. On average, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on DHR shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. TD Cowen decreased their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Jefferies Financial Group reiterated a “buy” rating and issued a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. HSBC cut their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Finally, Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.